Lisata Therapeutics (LSTA) Stock Chart & Stock Price History → Guard Against the Coming Financial Upheaval (From Porter & Company) (Ad) Free LSTA Stock Alerts $2.78 -0.17 (-5.77%) (As of 05/13/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Lisata Therapeutics Stock Price Performance5 Day Performance-4.64%1 Month Performance-4.31%3 Month Performance+0.18%6 Month Performance+24.44%Year-To-Date Performance+1.65%1 Year Performance-15.91% Receive LSTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Porter & CompanyWhat’s Really Next for America…Millions of Unsuspecting Americans Could be Wiped Out… Yet those who watch this bombshell exposé and prepare before it’s too late could have the chance to protect their financial future and grow their wealth significantly.Click here to stream this controversial exposé now. LSTA Stock Chart for Tuesday, May, 14, 2024 LSTA Chart by TradingView Lisata Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/13/2024$2.95$2.78-5.76%$2.95$2.655,475 shs$23.10 million05/10/2024$2.91$2.81-3.44%$2.95$2.774,893 shs$23.34 million05/09/2024$2.80$2.91+3.93%$2.91$2.702,892 shs$24.17 million05/08/2024$2.75$2.80+1.82%$2.80$2.80110 shs$23.26 million05/07/2024$2.77$2.75-0.72%$2.81$2.754,156 shs$23.01 million05/06/2024$2.85$2.77-2.81%$2.87$2.724,061 shs$23.02 million Get the Latest News and Ratings for LSTA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 05/03/2024$2.93$2.85-2.73%$2.94$2.649,141 shs$23.68 million05/02/2024$2.85$2.93+2.69%$3.00$2.5110,295 shs$24.34 million05/01/2024$2.73$2.85+4.51%$2.86$2.7114,108 shs$23.71 million04/30/2024$2.75$2.73-0.73%$2.90$2.619,431 shs$22.69 million04/29/2024$2.65$2.75+3.86%$2.90$2.525,406 shs$22.85 million04/26/2024$2.66$2.65-0.46%$2.78$2.614,678 shs$22.00 million04/25/2024$2.77$2.66-3.97%$2.90$2.636,093 shs$22.11 million04/24/2024$2.65$2.77+4.53%$2.89$2.569,552 shs$23.02 million04/23/2024$2.67$2.65-0.75%$2.81$2.5513,145 shs$22.01 million04/22/2024$2.70$2.67-1.11%$2.71$2.651,894 shs$22.19 million04/19/2024$2.85$2.70-5.26%$2.87$2.671,975 shs$22.44 million04/18/2024$2.78$2.85+2.52%$2.86$2.731,130 shs$23.68 million04/17/2024$2.87$2.78-3.14%$2.94$2.706,684 shs$23.10 million04/16/2024$2.83$2.87+1.41%$2.88$2.684,339 shs$23.85 million04/15/2024$2.90$2.83-2.41%$2.99$2.833,332 shs$23.52 million04/12/2024$3.09$2.90-6.15%$3.10$2.8723,026 shs$24.10 million04/11/2024$3.04$3.09+1.64%$3.11$2.8819,427 shs$25.68 million04/10/2024$3.02$3.04+0.66%$3.09$2.876,831 shs$25.26 million04/09/2024$2.90$3.02+4.14%$3.19$2.8325,544 shs$25.09 million04/08/2024$3.07$2.90-5.54%$3.02$2.855,578 shs$24.10 million04/05/2024$3.02$3.02$3.09$2.8412,058 shs$25.10 million04/04/2024$3.05$3.02-0.98%$3.06$2.969,584 shs$25.09 million04/03/2024$3.08$3.05-0.97%$3.10$3.032,263 shs$25.35 million04/02/2024$3.10$3.08-0.62%$3.12$3.016,109 shs$25.60 million04/01/2024$3.12$3.10-0.67%$3.20$3.1015,334 shs$25.75 million03/29/2024$3.12$3.12$3.27$3.1014,230 shs$25.92 million03/28/2024$3.23$3.12-3.41%$3.27$3.1014,029 shs$25.93 million03/27/2024$3.17$3.23+1.79%$3.27$3.1111,964 shs$26.84 million03/26/2024$3.29$3.17-3.55%$3.26$3.0814,018 shs$26.37 million03/25/2024$3.20$3.29+2.81%$3.38$3.0812,599 shs$27.34 million03/22/2024$3.35$3.20-4.48%$3.40$3.0423,304 shs$26.59 million03/21/2024$3.09$3.35+8.41%$3.40$3.00166,839 shs$27.84 million03/20/2024$3.06$3.09+0.98%$3.16$2.9951,396 shs$25.68 million03/19/2024$3.04$3.06+0.66%$3.12$2.938,751 shs$25.25 millionAmerica’s worst nightmare? (Ad)What This Group Has Planned for the 2024 Election Will Shock You Controversial new exposé reveals what’s really going on in America, what it means for your money, and what you must do to protect your assets before it’s too late.Click here to watch this bombshell exposé now.03/18/2024$3.08$3.04-1.30%$3.12$3.042,347 shs$25.26 million03/15/2024$3.03$3.08+1.65%$3.26$3.043,156 shs$25.60 million03/14/2024$3.06$3.03-0.98%$3.20$3.0010,647 shs$25.18 million03/13/2024$3.10$3.06-1.29%$3.18$3.0511,008 shs$25.43 million03/12/2024$3.24$3.10-4.32%$3.24$3.0611,060 shs$25.76 million03/11/2024$3.17$3.24+2.21%$3.26$3.053,272 shs$26.92 million03/08/2024$3.06$3.17+3.59%$3.17$3.063,021 shs$26.34 million03/07/2024$3.09$3.06-1.04%$3.14$3.006,129 shs$25.43 million03/06/2024$3.12$3.09-0.89%$3.15$2.938,945 shs$25.70 million03/05/2024$3.24$3.12-3.68%$3.20$3.0010,826 shs$25.92 million03/04/2024$3.10$3.24+4.49%$3.24$3.0525,661 shs$26.92 million03/01/2024$2.93$3.10+5.80%$3.16$2.9410,562 shs$25.23 million02/29/2024$3.16$2.93-7.26%$3.29$2.9224,027 shs$23.85 million02/28/2024$3.18$3.16-0.64%$3.30$3.117,163 shs$25.72 million02/27/2024$3.02$3.18+5.30%$3.24$3.0618,853 shs$25.89 million02/26/2024$2.99$3.02+1.00%$3.10$3.0110,173 shs$24.58 million02/23/2024$3.00$2.99-0.33%$3.10$2.9113,685 shs$24.34 million02/22/2024$2.87$3.00+4.53%$3.09$2.806,763 shs$24.42 million02/21/2024$3.00$2.87-4.33%$2.99$2.857,713 shs$23.36 million02/20/2024$3.12$3.00-3.85%$3.10$3.0012,117 shs$24.42 million02/19/2024$3.12$3.12$3.12$2.6929,000 shs$25.40 million02/16/2024$2.87$3.04+5.92%$3.12$2.6926,667 shs$24.75 million02/15/2024$2.77$2.87+3.61%$2.87$2.6110,108 shs$23.36 million02/14/2024$2.76$2.77+0.36%$2.84$2.669,665 shs$22.55 million02/13/2024$2.72$2.76+1.47%$2.87$2.654,590 shs$22.47 million Related Companies: TherapeuticsMD Stock Chart Bullfrog AI Stock Chart CytoMed Therapeutics Stock Chart Cumberland Pharmaceuticals Stock Chart RenovoRx Stock Chart Lumos Pharma Stock Chart Synlogic Stock Chart Qilian International Holding Group Stock Chart Benitec Biopharma Stock Chart Sol-Gel Technologies Stock Chart Receive LSTA Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Lisata Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LSTA) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersGuard Against the Coming Financial UpheavalPorter & CompanyClaim Your Complimentary Bitcoin RewardCrypto Swap ProfitsConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceCharles Payne Demystifies OptionsUnstoppable ProsperityForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm PressGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Lisata Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.